Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development
- PMID: 29484641
- PMCID: PMC7162218
- DOI: 10.1002/cpt.1034
Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development
Abstract
Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the "omics" approaches, reevaluate the suitable therapeutic targets, resolve the problems of inadequate animal modeling, develop the strategies to reduce the heterogeneity, and reconsider new therapeutic and analytical approaches for better designs of clinical trials.
© 2018 American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
The authors declare no competing interests for this work.
References
-
- Ashbaugh, D. , Bigelow, D.B. , Petty, T. & Levine, B. Acute respiratory distress in adults. Lancet 290, 319–323 (1967). - PubMed
-
- Ferguson, N.D. et al The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intens. Care Med. 38, 1573–1582 (2012). - PubMed
-
- Bernard, G.R. et al The American‐European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care. Med. 149, 818–824 (1994). - PubMed
-
- Force, A.D.T. Acute respiratory distress syndrome. JAMA 307, 2526–2533 (2012). - PubMed
-
- Thompson, B.T. , Chambers, R.C. & Liu, K.D. Acute respiratory distress syndrome. N. Engl. J. Med. 377, 562–572 (2017). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
